Form 4: Nanophase Technologies Director Janet Whitmore Acquires and Converts Shares
SEC Form 4
Director Janet Whitmore increased her holdings in Nanophase Technologies through open market purchases and the conversion of stock appreciation rights into stock options.
Summary
- On October 29, 2024, Janet Whitmore, a director of Nanophase Technologies Corp (NANX), engaged in multiple transactions involving the company's common stock.
- Whitmore purchased a total of 48,333 shares of common stock through several open market transactions at prices ranging from $0.45 to $1.18 per share.
- She also converted stock appreciation rights into stock options with exercise prices ranging from $0.45 to $1.85.
- Following these transactions, Whitmore directly owns 2,049,142 shares of Nanophase Technologies Corp.
- She also holds deferred common stock representing the right to receive 20,030 shares upon termination of her service as a director.
- The report was filed late due to an administrative error by the company, but Whitmore had complied with all required company policies and paid all funds due on October 29, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. While a director purchasing shares is generally positive, the late filing due to an administrative error introduces a negative element.
Positives
- A director's purchase of shares could be interpreted as a positive signal about the company's prospects.
Negatives
- The late filing of the report due to an administrative error could raise concerns about the company's internal controls.
Risks
- The administrative error leading to the late filing could indicate potential weaknesses in the company's compliance procedures.
- Fluctuations in the stock price could impact the value of Whitmore's holdings and the attractiveness of the stock options.
Management Comments
- Ms. Whitmore paid all funds due the Company and complied with all required Company policies on October 29, 2024.
Industry Context
Insider transactions are closely watched by investors as they can provide insights into management's view of the company's prospects. Purchases are generally seen as a positive sign, while sales may raise concerns.
Stakeholder Impact
- The director's stock purchases could boost investor confidence.
- The late filing might temporarily erode trust in the company's operational efficiency.
Key Dates
| Date | Description |
|---|---|
| 11/17/2016 | Date of stock options that expire 11/17/2026. |
| 11/17/2017 | Date of stock options that expire 11/17/2026. |
| 02/21/2018 | Date of stock options that expire 02/21/2027. |
| 05/23/2019 | Date of stock options that expire 05/23/2028. |
| 06/18/2021 | Date of stock options that expire 06/18/2027. |
| 12/28/2022 | Date of stock options that expire 12/28/2028. |
| 12/20/2023 | Date of stock options that expire 12/20/2029. |
| 12/27/2024 | Date of stock options that expire 12/27/2030. |
| 10/29/2024 | Date of transactions: stock purchases and conversion of stock appreciation rights to stock options. |
| 11/04/2024 | Date of the report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.